Home » Ligand, GSK Collaboration Identifies New Compound
Ligand, GSK Collaboration Identifies New Compound
Ligand Pharmaceuticals Incorporated announced that pursuant to an amendment to a March 2006 research agreement with GlaxoSmithKline, GSK has agreed to accelerate the timing of a $500,000 payment to Ligand that would otherwise have been required upon the identification of a new lead chemical series for advancement in its alliance with GSK.
News Blaze
News Blaze
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May